4/18/2025VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...

4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...

4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount

4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger

4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal

4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...

4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...

4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...

4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing

4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...

4/17/2025DualityBio Raises $211M in Hong Kong IPO

More>>

4/18/2025Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)

4/17/2025Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...

4/17/2025This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)

4/15/2025Off-Label Drug Use in China After the Physician Law (2021): Legal Chal...

4/14/2025China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...

4/14/2025Trump vs China Biotech: Who Will Emerge Victorious in the Tariff Trade...

4/8/2025NIH Ban Disrupts Some Chinese Genetics Research, But Broader Impact Se...

4/5/2025Analysis of China-to-West Pharmaceutical Licensing Deals in 2024 (Natu...

4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)

4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)

4/1/2025China's Pharma Industry Shows Signs of Recovery After Economic Downtur...

More>>